Longitudinal hemodiafilter performance in modeled continuous renal replacement therapy

Blood Purification

Volumn 32, Issue 2, 2011, Pages 82-88

  Pasko, Deborah A ^a,b   Churchwell, Mariann D ^b,c   Salama, Noha N ^b,d,e   Mueller, Bruce A ^a,b  

^a UNIVERSITY OF MICHIGAN   (United States)

^b Renal Replacement Therapy Kinetics Study Group   (United States)

^c UNIVERSITY OF TOLEDO   (United States)

^d ST LOUIS COLLEGE OF PHARMACY   (United States)

^e CAIRO UNIVERSITY   (Egypt)

Author keywords

Clearance; Continuous renal replacement therapy; Hemodialysis; Hemofiltration

Indexed keywords

ALBUMIN; CELLULOSE TRIACETATE; CREATININE; GENTAMICIN; POLYACRYLONITRILE; POLYSULFONE; VANCOMYCIN;

ALBUMIN BLOOD LEVEL; ARTICLE; BLOOD FILTER; CONTINUOUS HEMODIALYSIS; CONTINUOUS HEMOFILTRATION; CREATININE CLEARANCE; DIALYSATE; DRUG CLEARANCE; FLOW RATE; HUMAN; IN VITRO STUDY; OUTCOME ASSESSMENT; PRIORITY JOURNAL; UREA BLOOD LEVEL; UREA NITROGEN BLOOD LEVEL;

ADSORPTION; ANIMALS; BIOCOMPATIBLE MATERIALS; BLOOD CHEMICAL ANALYSIS; CATTLE; CREATININE; DIALYSIS SOLUTIONS; GENTAMICINS; HEMOFILTRATION; HUMANS; KINETICS; MEMBRANES, ARTIFICIAL; POLYMERS; RENAL DIALYSIS; RENAL REPLACEMENT THERAPY; SERUM ALBUMIN, BOVINE; TIME FACTORS; UREA; VANCOMYCIN;

EID: 79952105014     PISSN: 02535068     EISSN: 14219735     Source Type: Journal    
DOI: 10.1159/000324191     Document Type: Article

References (24)

1. Clark WR, Mueller BA, Alaka KJ, Macias WL: A comparison of metabolic control by continuous and intermittent therapies in acute renal failure. J Am Soc Nephrol 1994; 4: 1413-1420.
2. Mueller BA, Pasko DA, Sowinski KM: Higher renal replacement therapy dose delivery influences on drug therapy. Artif Organs 2003; 27: 808-814. (Pubitemid 37108621)
3. Stevenson JM, Patel JH, Churchwell MD, Vilay AM, DePestel DD, Sörgel F, Kinzig M, Jakob V, Mueller BA: Ertapenem clearance during modeled continuous renal replacement therapy. Int J Artif Organs 2008: 1027-1034.
4. Churchwell MD, Pasko DA, Mueller BA: Daptomycin clearance during modeled continuous renal replacement therapy. Blood Purif 2006; 24: 548-554. (Pubitemid 46030098)
5. Schetz M: Drug dosing in continuous renal replacement therapy: General rules. Curr Opin Crit Care 2007; 13: 645-651. (Pubitemid 350059527)
6. Aronoff GR, Bennett WM, Berns JS, Brier ME, Kasbekar N, Mueller BA, Pasko DA, Smoyer WE (eds): Drug Prescribing in Renal Failure: Dosing Guidelines for Adults and Children, ed 5. Philadelphia, American College of Physicians, 2007.
7. Churchwell MD, Pasko DA, Btaiche IF, Jain JC, Mueller BA: Trace element removal during in vitro and in vivo continuous haemodialysis. Nephrol Dial Transplant 2008; 22: 2970-2977. (Pubitemid 350093442)
8. Macias WL, Alaka KJ, Murphy MH, Miller ME, Clark WR, Mueller BA: Impact of the nutritional regimen on protein catabolism and nitrogen balance in patients with acute renal failure. J Parenteral Enteral Nutr 1996; 20: 56-62. (Pubitemid 26032938)
9. Maxvold NJ, Smoyer WE, Custer JR, Bunchman TE: Amino acid loss and nitrogen balance in critically ill children with acute renal failure: A prospective comparison between classic hemofiltration and hemofiltration with dialysis. Crit Care Med 2000; 28: 1161-1165. (Pubitemid 30262095)
10. Rogiers P: Hemofiltration treatment of sepsis: Is it time for controlled trials? Kidney Int 1999; 72:S99-S103.
11. Bottoms G, Fessler J, Murphey E, Johnson M, Latshaw H, Mueller B, Clark W, Macias W: Efficacy of convective removal of plasma mediators of endotoxic shock by continuous veno-venous hemofiltration. Shock 1996; 5: 149-154. (Pubitemid 126727645)
12. Bellomo R, Tipping P, Boyce N: Continuous veno-venous hemofiltration with dialysis removes cytokines from the circulation of septic patients. Crit Care Med 1993; 4: 522-526. (Pubitemid 23121799)
13. De Vriese AS, Colardyn FA, Philippe JJ, Vanholder RC, De Sutter JH, Lamiere NH: Cytokine removal during continuous hemofiltration in septic patients. J Am Soc Nephrol 1999; 10: 846-853. (Pubitemid 29149536)
14. Tian Q, Gomersall CD, Ip M, Tan TE, Joynt GM, Choi G: Adsorption of amikacin, a significant mechanism of elimination by hemofiltration. Antimicrob Agent Chemother 2008; 53: 1009-1013. (Pubitemid 351358381)
15. Choi G, Gomersall CD, Lipman J, Wong A, Joynt GM, Leung P, Ramsay SJ, Ho OM: The effect of adsorption, filter material and point of dilution on antibiotic elimination by haemofiltration. An in vitro study of levofloxacin. Int J Antimicrob Agents 2004; 24: 468-472. (Pubitemid 39425159)
16. Tian Q, Gomersall CD, Leung PN, Choi G, Joynt GM, Tan PE, Wong A: The adsorption of vancomycin by polyacrylonitrile, polyamide, and polysulfone hemofilters. Artif Organs 2008; 32: 81-84.
17. Clark WR, Macias WL, Molitoris BA, Wang NH: Plasma protein adsorption to highly permeable hemodialysis membranes. Kidney Int 1995; 48: 481-485.
18. Martin PY, Chevrolet JC, Suter P, Favre H: Anticoagulation in patients treated by continuous venovenous hemofiltration: A retrospective study. Am J Kidney Dis 1994; 24: 806-812. (Pubitemid 24350468)
19. Swartz R, Pasko DA, O'Toole J, Starmann B: Improving the delivery of continuous renal replacement therapy using regional citrate anticoagulation. Clin Nephrol 2004; 61: 134-143. (Pubitemid 38219910)
20. Sigler MH, Manns M: Membranes and devices used in continuous renal replacement. Semin Dial 1996; 9: 98-106. (Pubitemid 126670275)
21. Marshall MR: Current status of dosing and quantification of acute renal replacement therapy. 2. Dosing paradigms and clinical implementation. Nephrol Dial Transplant 2006; 11: 181-191. (Pubitemid 43829435)
22. Mehta RL, Martin RK: Initiating and implementing a continuous renal replacement therapy program. Semin Dial 1996; 9: 80-87. (Pubitemid 126670272)
23. Wei J, Granado RC, Malhotra R, Macedo E, Luo Y, Soroko S, Mehta RL: The impact of down-time and filter efficacy on delivered dose of continuous renal replacement therapy. J Am Soc Nephrol 2010; 21: 38A.
24. Uchino S, Cole L, Morimatsu H, Goldsmith D, Bellow R: Clearance of vancomycin during high-volume haemofiltration: Impact of pre-dilution. Intens Care Med 2002; 28: 1664-1667. (Pubitemid 36002520)